Haim Zaltzman

Mr. Zaltzman's representative transactions include:

• Hundreds of growth companies and their sponsors in every kind of financing
• Multiple direct lenders and investors in the life sciences space, including venture, structured, royalty, and other IP-related financings
• Various investors in late stage, growth capital, including pre-IPO converts, SPAC financings, redeemable and non-redeemable preferred, SPAC-related structures, and other secured and unsecured financings, to technology companies 
• Various private equity and venture capital firms in debt and equity financings of all types
• Multiple technology and life sciences companies and sponsors in deSPAC transactions 
• Multiple lenders and companies in securitization-related transactions

Prior Professional Experience

• Former Editor of the Stanford Journal of International Relations
• Fulbright Scholar in Russia
• Prior to Latham & Watkins, attorney in the New York office of Skadden, Arps, Slate, Meagher & Flom LLP

Thought Leadership

• Extending Your Reach: New Approaches to Values-Based Compliance and Contracting, January 5, 2023
• Emerging Growth Debt, Venture Capital General Counsel Meeting, Boulder, Colorado, March 29-30, 2017
• Financing Emerging Growth Companies with Debt, Webcast, May 4, 2017
• The Healthcare & Technology Industries’ Burgeoning Emerging Growth Debt Market, March 13, 2015
• When Venture Funding is Debt, Not Equity, June 22, 2011
• After the Credit Crunch: Venture Credit Facilities at the Term Sheet Stage, June 20, 2011